ReviewMolecular systems biology2026
Toward trustworthy healthcare AI: designing academic research for translation readiness.
Review in Molecular systems biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
In controlled proof-of-concept studies, healthcare artificial intelligence (AI) systems now routinely match or exceed specialist-level performance. Despite these impressive technical achievements, most systems remain confined to research settings, highlighting an opportunity to better prepare academic AI research for subsequent clinical translation. Successful translation requires attention to technical, regulatory, organizational, and infrastructural factors, ideally from the earliest stages of research. This Perspective focuses on trustworthiness as a key factor that academic researchers can address proactively. First, we outline how trustworthiness requirements differ across three stakeholder groups-patients, clinicians, and regulatory bodies-and how academic research can better align with these expectations. We then discuss key dimensions of trustworthy AI-explainability, uncertainty quantification, and evaluation-and how researchers can address them during study design. We also consider foundation models, which require adapted validation approaches. Based on this analysis, we propose a stakeholder-centered framework that emphasizes proactive integration of trust requirements during early development phases rather than post hoc considerations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.